首页 > 最新文献

Journal of Otolaryngology - Head & Neck Surgery最新文献

英文 中文
Alternative Sources of Cautery in Thyroid Surgery and the Risk of Recurrent Laryngeal Nerve Injury: A Retrospective, Risk-Adjusted Analysis From the National Surgical Quality Improvement Program. 甲状腺手术中灼烧剂的替代来源与喉神经复发性损伤的风险:国家外科手术质量改进计划的回顾性风险调整分析》。
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241265687
Corliss A E Best, Jumana Hussain, Stephanie Johnson-Obaseki

Objectives: A risk-adjusted analysis was completed using data from the National Surgical Quality Improvement Program (NSQIP) to compare the rates of recurrent laryngeal nerve injury in thyroid surgery using traditional versus alternative sources of cautery (defined as Harmonic Scalpel© and LigaSure©).

Methods: A retrospective cohort study was completed using the NSQIP database on adult patients who underwent total thyroidectomy, subtotal thyroidectomy, or completion thyroidectomy between 2016 and 2018. The primary outcome measure was recurrent laryngeal nerve injury. The exposure variable was use of conventional or alternative sources of cautery. Multivariable linear and logistic regression analyses were performed to control for potentially confounding variables.

Results: A total of 13,961 cases were analyzed; 9450 used alternative sources of cautery compared to 4511 where traditional cautery was used. There was no significant difference in rates of postoperative recurrent laryngeal nerve injury between the 2 sources of cautery compared.

Conclusions: Risk of recurrent laryngeal nerve injury should not be a factor when choosing method of cautery for thyroid surgery. Therefore, other factors like cost-effectiveness can be considered.

目的:利用国家外科质量改进计划(NSQIP)的数据完成一项风险调整分析,比较使用传统烧灼法和替代烧灼法(定义为 Harmonic Scalpel© 和 LigaSure©)进行甲状腺手术的喉返神经损伤率:利用 NSQIP 数据库完成了一项回顾性队列研究,研究对象为 2016 年至 2018 年期间接受甲状腺全切术、甲状腺次全切术或甲状腺完全切除术的成年患者。主要结局指标为喉返神经损伤。暴露变量为使用传统或替代烧灼源。进行了多变量线性和逻辑回归分析,以控制潜在的混杂变量:共分析了13961个病例,其中9450个病例使用了替代烧灼法,4511个病例使用了传统烧灼法。两种烧灼法的术后喉返神经损伤率没有明显差异:结论:在选择甲状腺手术的烧灼方法时,喉返神经损伤的风险不应作为考虑因素。因此,可以考虑成本效益等其他因素。
{"title":"Alternative Sources of Cautery in Thyroid Surgery and the Risk of Recurrent Laryngeal Nerve Injury: A Retrospective, Risk-Adjusted Analysis From the National Surgical Quality Improvement Program.","authors":"Corliss A E Best, Jumana Hussain, Stephanie Johnson-Obaseki","doi":"10.1177/19160216241265687","DOIUrl":"10.1177/19160216241265687","url":null,"abstract":"<p><strong>Objectives: </strong>A risk-adjusted analysis was completed using data from the National Surgical Quality Improvement Program (NSQIP) to compare the rates of recurrent laryngeal nerve injury in thyroid surgery using traditional versus alternative sources of cautery (defined as Harmonic Scalpel<sup>©</sup> and LigaSure<sup>©</sup>).</p><p><strong>Methods: </strong>A retrospective cohort study was completed using the NSQIP database on adult patients who underwent total thyroidectomy, subtotal thyroidectomy, or completion thyroidectomy between 2016 and 2018. The primary outcome measure was recurrent laryngeal nerve injury. The exposure variable was use of conventional or alternative sources of cautery. Multivariable linear and logistic regression analyses were performed to control for potentially confounding variables.</p><p><strong>Results: </strong>A total of 13,961 cases were analyzed; 9450 used alternative sources of cautery compared to 4511 where traditional cautery was used. There was no significant difference in rates of postoperative recurrent laryngeal nerve injury between the 2 sources of cautery compared.</p><p><strong>Conclusions: </strong>Risk of recurrent laryngeal nerve injury should not be a factor when choosing method of cautery for thyroid surgery. Therefore, other factors like cost-effectiveness can be considered.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241265687"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11284774/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141788372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Necessary Factors for Efficient Frontal Sinus Irrigation After Endoscopic Sinus Surgery: A Systematic Review. 内窥镜鼻窦手术后有效冲洗额窦的必要因素:系统回顾
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241269375
Yingting Qi, Junsheng Hong, Dawei Wu

Objective: The frontal sinus remains a challenging site for irrigation due to its position relative to the nostril and ethmoid sinus. This study aims to summarize the necessary factors for efficient irrigation of the frontal sinus after endoscopic sinus surgery (ESS) among patients with chronic rhinosinusitis (CRS).

Methods: Using Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, a systematic literature review was conducted on PubMed, Scopus, and Cochrane databases to identify studies assessing the effect of frontal sinus irrigation in patients with CRS, cadaver models, or 3D-printed models of the sinonasal cavity after ESS.

Results: Of the initial 206 abstracts reviewed, 18 full-text articles were included. The degree of the frontal sinus ostium opening after ESS was found to be associated with the efficacy of frontal sinus irrigation. More extensive frontal sinus surgeries tended to increase frontal sinus penetration. A Draf IIA procedure was identified as the minimum standard to achieve sufficient irrigation in the frontal sinus. Due to decreased backpressure in the nasal passage, increasing septectomy in Draf III did not significantly improve irrigation delivery. Squeeze bottles achieved significantly higher irrigation flow in the frontal sinus than syringes and pulsating devices. Large-volume irrigation devices provided better irrigation for the frontal sinus by entering or flushing the entire frontal sinus. The head position influenced the frontal sinus irrigation by altering the ostia position relative to fluid flow and vertical height of the frontal sinus during irrigation. While the vertex down head position was likely to enhance frontal sinus irrigation, the comfort of the head position and patient compliance should be considered.

Conclusion: Elements for optimization of frontal sinus irrigation are a minimum of a Draf IlA procedure for frontal sinus dissection, use of large-volume irrigation, and vertex down head positioning. Developing comfortable head positions with high frontal sinus irrigation efficiency would increase patient compliance and improve outcomes.

Level of evidence: NA.

目的:由于额窦与鼻孔和乙状窦的相对位置,额窦仍是一个具有挑战性的灌洗部位。本研究旨在总结慢性鼻窦炎(CRS)患者进行内窥镜鼻窦手术(ESS)后有效灌洗额窦的必要因素:采用系统综述和荟萃分析首选报告项目(Preferred Reporting Items for Systematic Reviews and Meta-Analysis,PRISMA)指南,在PubMed、Scopus和Cochrane数据库中进行了系统文献综述,以确定评估CRS患者额窦灌洗效果的研究、尸体模型或ESS术后鼻窦腔3D打印模型:结果:在最初审查的 206 篇摘要中,有 18 篇全文被收录。研究发现,ESS术后额窦骨膜的开放程度与额窦灌洗的疗效有关。额窦手术范围越大,额窦穿透力越强。Draf IIA 手术被认为是实现额窦充分冲洗的最低标准。由于鼻腔内的背压降低,在 Draf III 中增加鼻中隔切除术并不能明显改善灌洗效果。与注射器和脉动装置相比,挤压瓶在额窦的灌洗流量明显更高。大流量冲洗装置通过进入或冲洗整个额窦为额窦提供了更好的冲洗。在冲洗过程中,头部位置通过改变相对于流体的骨孔位置和额窦的垂直高度来影响额窦冲洗。虽然头顶向下的位置可能会加强额窦冲洗,但应考虑头部位置的舒适性和患者的顺从性:额窦灌洗的优化要素包括额窦剥离的最低Draf IlA程序、大容量灌洗的使用以及头顶向下的体位。发展舒适的头部姿势,提高额窦灌洗效率,将提高患者的依从性并改善疗效:不适用。
{"title":"Necessary Factors for Efficient Frontal Sinus Irrigation After Endoscopic Sinus Surgery: A Systematic Review.","authors":"Yingting Qi, Junsheng Hong, Dawei Wu","doi":"10.1177/19160216241269375","DOIUrl":"10.1177/19160216241269375","url":null,"abstract":"<p><strong>Objective: </strong>The frontal sinus remains a challenging site for irrigation due to its position relative to the nostril and ethmoid sinus. This study aims to summarize the necessary factors for efficient irrigation of the frontal sinus after endoscopic sinus surgery (ESS) among patients with chronic rhinosinusitis (CRS).</p><p><strong>Methods: </strong>Using Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines, a systematic literature review was conducted on PubMed, Scopus, and Cochrane databases to identify studies assessing the effect of frontal sinus irrigation in patients with CRS, cadaver models, or 3D-printed models of the sinonasal cavity after ESS.</p><p><strong>Results: </strong>Of the initial 206 abstracts reviewed, 18 full-text articles were included. The degree of the frontal sinus ostium opening after ESS was found to be associated with the efficacy of frontal sinus irrigation. More extensive frontal sinus surgeries tended to increase frontal sinus penetration. A Draf IIA procedure was identified as the minimum standard to achieve sufficient irrigation in the frontal sinus. Due to decreased backpressure in the nasal passage, increasing septectomy in Draf III did not significantly improve irrigation delivery. Squeeze bottles achieved significantly higher irrigation flow in the frontal sinus than syringes and pulsating devices. Large-volume irrigation devices provided better irrigation for the frontal sinus by entering or flushing the entire frontal sinus. The head position influenced the frontal sinus irrigation by altering the ostia position relative to fluid flow and vertical height of the frontal sinus during irrigation. While the vertex down head position was likely to enhance frontal sinus irrigation, the comfort of the head position and patient compliance should be considered.</p><p><strong>Conclusion: </strong>Elements for optimization of frontal sinus irrigation are a minimum of a Draf IlA procedure for frontal sinus dissection, use of large-volume irrigation, and vertex down head positioning. Developing comfortable head positions with high frontal sinus irrigation efficiency would increase patient compliance and improve outcomes.</p><p><strong>Level of evidence: </strong>NA.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241269375"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11304481/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brazilian Version of the Vestibular Activities and Participation Measure: Cross-Cultural Adaptation, Validity, and Reliability. 巴西版前庭活动和参与度测量:跨文化适应性、有效性和可靠性。
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241250353
Maria das Graças de Araújo Lira, Susan L Whitney, Thais Cristina Chaves, Karyna Myrelly Oliveira Bezerra de Figueiredo-Ribeiro

Background: Vestibular Activities and Participation Measure (VAP) subscales assess the effect of vestibular disorders on activity and participation. This study aimed to perform the cross-cultural adaptation and assess the validity, internal consistency, reliability, and measurement error of the Brazilian version of VAP subscales.

Methods: The cross-cultural adaptation followed the translation, synthesis, back-translation, review by a committee of experts, and pretesting phases. Structural validity was assessed using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA), while Spearman's correlation between VAP subscales and the Dizziness Handicap Inventory (DHI) was used to assess construct validity. Cronbach's alpha measured internal consistency. Intraclass correlation coefficient (ICC) assessed intra- and inter-rater reliability, and measurement error was calculated by using the standard error of measurement (SEM) and minimal detectable change (MDC).

Results: Additional information was included in the Brazilian version of the Vestibular Activities and Participation measure (VAP-BR) after approval by one of the developers of the instrument to improve the understanding among individuals. One factor was found in the EFA for each subscale with 50% explained variance. Regarding CFA, the subscales 1 (S1) and 2 (S2) presented, respectively, adequate model fit indices (ie, comparative fit index of 0.99 and 0.97, and standardized root mean square residual of 0.04 for both subscales), but a very low factor load in item 6 of S1 (0.08). Chronbach's alpha was 0.80 (S1) and 0.82 (S2). For intra-rater assessment, the S1 and S2 presented an ICC of 0.87 and 0.90, SEM of 0.01 and 1.16, and MDC of 0.39 and 0.46, respectively. When assessed by 2 different raters, SEM values were 1.03 and 1.53, and MDC values were 2.85 and 4.23 for S1 and S2, respectively; both subscales showed an ICC of 0.92. Correlations between DHI and VAP subscales presented coefficients above 0.57.

Conclusion: The Brazilian version of VAP subscales presents good measurement properties and may assist health professionals in identifying activity limitations and participation restrictions in individuals with vestibular disorders.

背景:前庭活动和参与测量(VAP)分量表评估前庭障碍对活动和参与的影响。本研究旨在对巴西版 VAP 分量表进行跨文化改编,并评估其有效性、内部一致性、可靠性和测量误差:跨文化改编经过了翻译、综合、回译、专家委员会审查和预测试阶段。结构效度采用探索性因子分析(EFA)和确认性因子分析(CFA)进行评估,而 VAP 分量表与头晕障碍量表(DHI)之间的斯皮尔曼相关性则用于评估结构效度。Cronbach's alpha 用于测量内部一致性。类内相关系数(ICC)评估了评分者内部和评分者之间的可靠性,测量误差则通过测量标准误差(SEM)和最小可检测变化(MDC)来计算:在巴西版前庭活动和参与度测量(VAP-BR)中加入了更多信息,这些信息得到了该工具开发者之一的认可,以增进个人之间的理解。在 EFA 中,每个子量表都有一个因子,解释方差为 50%。就 CFA 而言,子量表 1(S1)和子量表 2(S2)的模型拟合指数分别为 0.99 和 0.97,两个子量表的标准化均方根残差均为 0.04,但 S1 第 6 项的因子载荷很低(0.08)。Chronbach'sα为 0.80(S1)和 0.82(S2)。在评分者内部评估方面,S1 和 S2 的 ICC 分别为 0.87 和 0.90,SEM 分别为 0.01 和 1.16,MDC 分别为 0.39 和 0.46。由两名不同评分者进行评估时,S1 和 S2 的 SEM 值分别为 1.03 和 1.53,MDC 值分别为 2.85 和 4.23;两个分量表的 ICC 均为 0.92。DHI 与 VAP 分量表之间的相关系数高于 0.57:巴西版 VAP 分量表具有良好的测量特性,可帮助医疗专业人员识别前庭障碍患者的活动限制和参与限制。
{"title":"Brazilian Version of the Vestibular Activities and Participation Measure: Cross-Cultural Adaptation, Validity, and Reliability.","authors":"Maria das Graças de Araújo Lira, Susan L Whitney, Thais Cristina Chaves, Karyna Myrelly Oliveira Bezerra de Figueiredo-Ribeiro","doi":"10.1177/19160216241250353","DOIUrl":"10.1177/19160216241250353","url":null,"abstract":"<p><strong>Background: </strong>Vestibular Activities and Participation Measure (VAP) subscales assess the effect of vestibular disorders on activity and participation. This study aimed to perform the cross-cultural adaptation and assess the validity, internal consistency, reliability, and measurement error of the Brazilian version of VAP subscales.</p><p><strong>Methods: </strong>The cross-cultural adaptation followed the translation, synthesis, back-translation, review by a committee of experts, and pretesting phases. Structural validity was assessed using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA), while Spearman's correlation between VAP subscales and the Dizziness Handicap Inventory (DHI) was used to assess construct validity. Cronbach's alpha measured internal consistency. Intraclass correlation coefficient (ICC) assessed intra- and inter-rater reliability, and measurement error was calculated by using the standard error of measurement (SEM) and minimal detectable change (MDC).</p><p><strong>Results: </strong>Additional information was included in the Brazilian version of the Vestibular Activities and Participation measure (VAP-BR) after approval by one of the developers of the instrument to improve the understanding among individuals. One factor was found in the EFA for each subscale with 50% explained variance. Regarding CFA, the subscales 1 (S1) and 2 (S2) presented, respectively, adequate model fit indices (ie, comparative fit index of 0.99 and 0.97, and standardized root mean square residual of 0.04 for both subscales), but a very low factor load in item 6 of S1 (0.08). Chronbach's alpha was 0.80 (S1) and 0.82 (S2). For intra-rater assessment, the S1 and S2 presented an ICC of 0.87 and 0.90, SEM of 0.01 and 1.16, and MDC of 0.39 and 0.46, respectively. When assessed by 2 different raters, SEM values were 1.03 and 1.53, and MDC values were 2.85 and 4.23 for S1 and S2, respectively; both subscales showed an ICC of 0.92. Correlations between DHI and VAP subscales presented coefficients above 0.57.</p><p><strong>Conclusion: </strong>The Brazilian version of VAP subscales presents good measurement properties and may assist health professionals in identifying activity limitations and participation restrictions in individuals with vestibular disorders.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241250353"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11307343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141897590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Canadian Real-World Study Long-Term Clinical Results Using Dupilumab for Chronic Rhinosinusitis With Polyps. 加拿大真实世界研究使用杜比鲁单抗治疗慢性鼻窦炎伴息肉的长期临床结果。
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241278659
Shaun J Kilty, Andrea Lasso

Background: Dupilumab, an anti-IL4 receptor-α monoclonal antibody, was the first biologic to be approved in Canada for the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). In phase III clinical trials, it has demonstrated to be effective in reducing nasal polyp size and the severity of symptoms, improve disease-specific quality of life, and to have an acceptable safety profile. This study aims to present long-term follow-up data on disease-specific sinonasal outcomes of patients with CRSwNP who have been treated with dupilumab for up to 3 years in a real-world setting.

Methods: Retrospective review of electronic medical records of a single Canadian rhinology center evaluating disease-specific sinonasal outcomes that are routinely collected for clinical care. This study included all patients who received dupilumab for the treatment of CRSwNP and who had completed at least one follow-up visit. The Sino-Nasal Outcome Test (SNOT)-22 was used to evaluate treatment symptom improvement.

Results: Ninety-nine patients started dupilumab therapy during the study period. The mean SNOT-22 at the start of therapy was 61.1 (±22.91) At the time of the review, 65 patients had completed 1 year of therapy, 40 had completed 2 years of therapy, and 18 had completed 3 years of therapy. The mean SNOT-22 score at these timepoints was 16.75 (±13.86), 15.02 (±14.40), and 10.22 (±11.56), respectively.

Conclusion: This real-world study shows that in patients with CRSwNP treated with dupilumab, improvement in disease-specific quality of life seen after 1 year continues and can be maintained at 3 years of treatment.

背景介绍Dupilumab是一种抗IL4受体-α单克隆抗体,是加拿大首个获准用于治疗慢性鼻炎伴鼻息肉(CRSwNP)的生物制剂。在 III 期临床试验中,该药已被证明能有效缩小鼻息肉的大小、减轻症状的严重程度、改善疾病相关的生活质量,并且具有可接受的安全性。本研究旨在提供在真实世界中接受杜必鲁单抗治疗长达 3 年的 CRSwNP 患者鼻窦特异性疾病结果的长期随访数据:方法:对加拿大一家鼻科中心的电子病历进行回顾性审查,评估临床护理常规收集的疾病特异性鼻窦疗效。这项研究包括所有接受过杜比单抗治疗的 CRSwNP 患者,他们至少完成了一次随访。结果显示,99 名患者开始使用杜普鲁单抗治疗 CRSwNP,并完成了至少一次随访:结果:99 名患者在研究期间开始接受杜必鲁单抗治疗。开始治疗时的 SNOT-22 平均值为 61.1(±22.91)分。在复查时,65 名患者已完成 1 年治疗,40 名患者已完成 2 年治疗,18 名患者已完成 3 年治疗。这些时间点的 SNOT-22 平均得分分别为 16.75(±13.86)分、15.02(±14.40)分和 10.22(±11.56)分:这项真实世界研究表明,接受杜比单抗治疗的 CRSwNP 患者在治疗 1 年后,疾病特异性生活质量会继续改善,并在治疗 3 年后仍能保持。
{"title":"Canadian Real-World Study Long-Term Clinical Results Using Dupilumab for Chronic Rhinosinusitis With Polyps.","authors":"Shaun J Kilty, Andrea Lasso","doi":"10.1177/19160216241278659","DOIUrl":"10.1177/19160216241278659","url":null,"abstract":"<p><strong>Background: </strong>Dupilumab, an anti-IL4 receptor-α monoclonal antibody, was the first biologic to be approved in Canada for the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). In phase III clinical trials, it has demonstrated to be effective in reducing nasal polyp size and the severity of symptoms, improve disease-specific quality of life, and to have an acceptable safety profile. This study aims to present long-term follow-up data on disease-specific sinonasal outcomes of patients with CRSwNP who have been treated with dupilumab for up to 3 years in a real-world setting.</p><p><strong>Methods: </strong>Retrospective review of electronic medical records of a single Canadian rhinology center evaluating disease-specific sinonasal outcomes that are routinely collected for clinical care. This study included all patients who received dupilumab for the treatment of CRSwNP and who had completed at least one follow-up visit. The Sino-Nasal Outcome Test (SNOT)-22 was used to evaluate treatment symptom improvement.</p><p><strong>Results: </strong>Ninety-nine patients started dupilumab therapy during the study period. The mean SNOT-22 at the start of therapy was 61.1 (±22.91) At the time of the review, 65 patients had completed 1 year of therapy, 40 had completed 2 years of therapy, and 18 had completed 3 years of therapy. The mean SNOT-22 score at these timepoints was 16.75 (±13.86), 15.02 (±14.40), and 10.22 (±11.56), respectively.</p><p><strong>Conclusion: </strong>This real-world study shows that in patients with CRSwNP treated with dupilumab, improvement in disease-specific quality of life seen after 1 year continues and can be maintained at 3 years of treatment.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241278659"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11450752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142348613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Proposed Quality Indicators for Aspects of Pediatric Acute Otitis Media Management. 小儿急性中耳炎管理质量指标建议。
IF 3.4 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241248538
Justin Cottrell, Amirpouyan Namavarian, Jonathan Yip, Paolo Campisi, Neil K Chadha, Ali Damji, Paul Hong, Sophie Lachance, Darren Leitao, Lily H P Nguyen, Natasha Saunders, Julie Strychowsky, Warren Yunker, Jean-Philippe Vaccani, Yvonne Chan, John R de Almeida, Antoine Eskander, Ian J Witterick, Eric Monteiro

Background: The high incidence of pediatric acute otitis media (AOM) makes the implications of overdiagnosis and overtreatment far-reaching. Quality indicators (QIs) for AOM are limited, drawing from generalized upper respiratory infection QIs, or locally developed benchmarks. Recognizing this, we sought to develop pediatric AOM QIs to build a foundation for future quality improvement efforts.

Methods: Candidate indicators (CIs) were extracted from existing guidelines and position statements. The modified RAND Corporation/University of California, Los Angeles (RAND/UCLA) appropriateness methodology was used to select the final QIs by an 11-member expert panel consisting of otolaryngology-head and neck surgeons, a pediatrician and family physician.

Results: Twenty-seven CIs were identified after literature review, with an additional CI developed by the expert panel. After the first round of evaluations, the panel agreed on 4 CIs as appropriate QIs. After an expert panel meeting and subsequent second round of evaluations, the panel agreed on 8 final QIs as appropriate measures of high-quality care. The 8 final QIs focus on topics of antimicrobial management, specialty referral, and tympanostomy tube counseling.

Conclusions: Evidence of variable and substandard care persists in the diagnosis and management of pediatric AOM despite the existence of high-quality guidelines. This study proposes 8 QIs which compliment guideline recommendations and are meant to facilitate future quality improvement initiatives that can improve patient outcomes.

背景:小儿急性中耳炎(AOM)发病率高,过度诊断和过度治疗的影响深远。针对 AOM 的质量指标(QIs)非常有限,只能借鉴通用的上呼吸道感染质量指标或当地制定的基准。有鉴于此,我们试图制定儿科 AOM 质量指标,为今后的质量改进工作奠定基础:方法:从现有指南和立场声明中提取候选指标(CIs)。由耳鼻咽喉头颈外科医生、儿科医生和家庭医生组成的 11 人专家小组采用修改后的兰德公司/加州大学洛杉矶分校(RAND/UCLA)适当性方法来选择最终的 QIs:结果:在查阅文献后,确定了 27 项 CI,专家组又制定了一项 CI。经过第一轮评估,专家组一致同意将 4 项 CI 作为适当的 QI。经过专家小组会议和随后的第二轮评估,专家小组同意将 8 项最终的 QI 作为衡量优质护理的适当指标。这 8 个最终的 QIs 重点关注抗菌素管理、专科转诊和鼓室造口管咨询等主题:结论:尽管有高质量的指南,但在儿科 AOM 的诊断和管理中仍存在护理不规范和不达标的情况。本研究提出了 8 项 QIs,这些 QIs 是对指南建议的补充,旨在促进未来的质量改进措施,从而改善患者的治疗效果。
{"title":"Proposed Quality Indicators for Aspects of Pediatric Acute Otitis Media Management.","authors":"Justin Cottrell, Amirpouyan Namavarian, Jonathan Yip, Paolo Campisi, Neil K Chadha, Ali Damji, Paul Hong, Sophie Lachance, Darren Leitao, Lily H P Nguyen, Natasha Saunders, Julie Strychowsky, Warren Yunker, Jean-Philippe Vaccani, Yvonne Chan, John R de Almeida, Antoine Eskander, Ian J Witterick, Eric Monteiro","doi":"10.1177/19160216241248538","DOIUrl":"10.1177/19160216241248538","url":null,"abstract":"<p><strong>Background: </strong>The high incidence of pediatric acute otitis media (AOM) makes the implications of overdiagnosis and overtreatment far-reaching. Quality indicators (QIs) for AOM are limited, drawing from generalized upper respiratory infection QIs, or locally developed benchmarks. Recognizing this, we sought to develop pediatric AOM QIs to build a foundation for future quality improvement efforts.</p><p><strong>Methods: </strong>Candidate indicators (CIs) were extracted from existing guidelines and position statements. The modified RAND Corporation/University of California, Los Angeles (RAND/UCLA) appropriateness methodology was used to select the final QIs by an 11-member expert panel consisting of otolaryngology-head and neck surgeons, a pediatrician and family physician.</p><p><strong>Results: </strong>Twenty-seven CIs were identified after literature review, with an additional CI developed by the expert panel. After the first round of evaluations, the panel agreed on 4 CIs as appropriate QIs. After an expert panel meeting and subsequent second round of evaluations, the panel agreed on 8 final QIs as appropriate measures of high-quality care. The 8 final QIs focus on topics of antimicrobial management, specialty referral, and tympanostomy tube counseling.</p><p><strong>Conclusions: </strong>Evidence of variable and substandard care persists in the diagnosis and management of pediatric AOM despite the existence of high-quality guidelines. This study proposes 8 QIs which compliment guideline recommendations and are meant to facilitate future quality improvement initiatives that can improve patient outcomes.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241248538"},"PeriodicalIF":3.4,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11098001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141419598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness Analysis of Molecular Testing for Indeterminate Thyroid Nodules in Nova Scotia. 新斯科舍省甲状腺结节不确定分子检测的成本效益分析。
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241291806
Colin MacKay, Brooke Turner, Scott Clarke, Timothy Wallace, Matthew H Rigby

Background: The objective of the following retrospective review was to perform a cost-effectiveness analysis of the use of molecular testing of indeterminate thyroid nodules compared to current management practices in Nova Scotia, Canada.

Methods: All cases of cytologically indeterminate thyroid nodules from January 1st, 2014 to December 31st, 2018 were reviewed. All interventions related to an indeterminate thyroid nodule were recorded. Patients were excluded if less than 18 years old if no further information regarding medical management was electronically available beyond the diagnosis of an indeterminate thyroid nodule, history of radiation, or previous thyroid surgery prior to diagnosis of an indeterminate thyroid nodule in the remaining lobe. Microcosting was performed to determine the cost of all relevant interventions including repeat fine needle aspiration biopsy, ultrasound, thyroid surgery(s), and molecular testing. Institution-specific transition state probabilities were calculated and used to build a cost-effectiveness analysis model. Model output was an incremental cost-effectiveness ratio, defined as the ratio of cost difference to effectiveness difference between routine molecular testing and the current management strategy, yielding cost per surgery avoided.

Results: The mean effectiveness of the current management of indeterminate thyroid nodules in Nova Scotia based on the American Thyroid Association guidelines is 64% at a mean cost of $6431, while the simulated mean effectiveness of routine molecular testing is 89% at a mean cost of $8414. Differences in management strategies generated an incremental cost-effectiveness ratio of $7876 per surgery avoided.

Conclusion: Routine molecular testing is the more effective strategy for the appropriate management of indeterminate thyroid nodules; however, it comes at a higher mean cost compared to the current management strategy. As the cost of molecular testing continues to decrease, and the cost of OR resources continues to rise, molecular testing is likely to become the optimal strategy in Nova Scotia.

背景:以下回顾性研究的目的是对加拿大新斯科舍省未确定甲状腺结节使用分子检测的成本效益进行分析,并与当前的管理方法进行比较:对2014年1月1日至2018年12月31日期间所有细胞学不确定甲状腺结节病例进行回顾性研究。记录了与不确定甲状腺结节相关的所有干预措施。如果除诊断为不确定甲状腺结节、放射史或在诊断为剩余叶不确定甲状腺结节之前曾进行过甲状腺手术外,没有其他有关医疗管理的电子信息,则排除年龄小于18岁的患者。进行微观成本计算以确定所有相关干预措施的成本,包括重复细针穿刺活检、超声检查、甲状腺手术和分子检测。计算了特定机构的过渡状态概率,并将其用于建立成本效益分析模型。模型的输出结果是增量成本效益比,即常规分子检测与现行管理策略之间的成本差异与效果差异之比,得出每避免一次手术的成本:新斯科舍省目前根据美国甲状腺协会指南对不确定甲状腺结节进行管理的平均有效率为 64%,平均成本为 6431 美元,而常规分子检测的模拟平均有效率为 89%,平均成本为 8414 美元。管理策略的差异导致每避免一次手术的增量成本效益比为7876美元:结论:常规分子检测是对不确定甲状腺结节进行适当管理的更有效策略;但与现行管理策略相比,其平均成本较高。随着分子检测成本的不断降低,以及手术室资源成本的不断上升,分子检测很可能成为新斯科舍省的最佳策略。
{"title":"Cost-Effectiveness Analysis of Molecular Testing for Indeterminate Thyroid Nodules in Nova Scotia.","authors":"Colin MacKay, Brooke Turner, Scott Clarke, Timothy Wallace, Matthew H Rigby","doi":"10.1177/19160216241291806","DOIUrl":"10.1177/19160216241291806","url":null,"abstract":"<p><strong>Background: </strong>The objective of the following retrospective review was to perform a cost-effectiveness analysis of the use of molecular testing of indeterminate thyroid nodules compared to current management practices in Nova Scotia, Canada.</p><p><strong>Methods: </strong>All cases of cytologically indeterminate thyroid nodules from January 1st, 2014 to December 31st, 2018 were reviewed. All interventions related to an indeterminate thyroid nodule were recorded. Patients were excluded if less than 18 years old if no further information regarding medical management was electronically available beyond the diagnosis of an indeterminate thyroid nodule, history of radiation, or previous thyroid surgery prior to diagnosis of an indeterminate thyroid nodule in the remaining lobe. Microcosting was performed to determine the cost of all relevant interventions including repeat fine needle aspiration biopsy, ultrasound, thyroid surgery(s), and molecular testing. Institution-specific transition state probabilities were calculated and used to build a cost-effectiveness analysis model. Model output was an incremental cost-effectiveness ratio, defined as the ratio of cost difference to effectiveness difference between routine molecular testing and the current management strategy, yielding cost per surgery avoided.</p><p><strong>Results: </strong>The mean effectiveness of the current management of indeterminate thyroid nodules in Nova Scotia based on the American Thyroid Association guidelines is 64% at a mean cost of $6431, while the simulated mean effectiveness of routine molecular testing is 89% at a mean cost of $8414. Differences in management strategies generated an incremental cost-effectiveness ratio of $7876 per surgery avoided.</p><p><strong>Conclusion: </strong>Routine molecular testing is the more effective strategy for the appropriate management of indeterminate thyroid nodules; however, it comes at a higher mean cost compared to the current management strategy. As the cost of molecular testing continues to decrease, and the cost of OR resources continues to rise, molecular testing is likely to become the optimal strategy in Nova Scotia.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241291806"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11494664/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142468073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of the "LAser Surgical skills Evaluation for Residents" (LASER) Scale Through a Modified Delphi Method. 通过改良德尔菲法开发 "住院医师手术技能评估"(LASER)量表。
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241278654
E Sédillot-Daniel, A Melkane, C Chiesa, N Fakhry, V N Young, L J Smith, J R Lechien, L Guertin, M J Olivier, A Maniakas, R Jun Lin, E Bissada, A Christopoulos, T Ayad, Andrée-Anne Leclerc

Background: The CO2 laser is frequently used during microlaryngeal surgery (MLS) for a variety of pathology including laryngeal malignancy and stenosis. Learning how to use the laser safely is part of the curriculum for every otolaryngology resident. However, assessment of laryngoscopy technical skills can be challenging for supervisors, making it difficult to adequately provide feedback to trainees.

Objectives: "LAser Surgical skills Evaluation for Residents" (LASER) Scale aims to facilitate the evaluation of residents' performance and promote constructive feedback.

Methods: The initial evaluation grid was based on a literature review of CO2 laser laryngoscopy (with an emphasis on indications, technique, safety, and efficacy) using Covidence systematic review software (Veritas Health Innovation). The final version was produced after 4 rounds of Delphi surveys.

Results: This study was an international collaboration including 15 otolaryngologists with either laryngology or head and neck surgery subspecialties. Panelists were based in Canada (8), the United States (3), France (1), Spain (1), Belgium (1), and Lebanon (1). The process involved 4 rounds of Delphi surveys. Assessment categories included: anesthesia considerations, pre- and perioperative laser safety measures, and surgical technique. Consensus was reached on final survey completion.

Conclusions: Through a modified Delphi method, a novel scale was developed through an international collaborative effort that evaluates resident skillset in CO2 laser MLS. Future studies are warranted to validate this assessment tool.

背景:喉显微手术(MLS)中经常使用二氧化碳激光治疗各种病症,包括喉恶性肿瘤和喉狭窄。学习如何安全使用激光是每位耳鼻喉科住院医师课程的一部分。然而,喉镜检查技术技能的评估对督导人员来说具有挑战性,因此很难向学员提供充分的反馈:目的:"住院医师喉镜手术技能评估"(LASER)量表旨在方便评估住院医师的表现并促进建设性反馈:方法:最初的评估量表是在使用 Covidence 系统综述软件(Veritas Health Innovation)对 CO2 激光喉镜检查(重点是适应症、技术、安全性和有效性)进行文献综述的基础上制定的。最终版本经过 4 轮德尔菲调查后产生:这项研究是一项国际合作项目,包括 15 位耳鼻喉科专家,他们都是喉科或头颈外科的亚专科医生。小组成员分别来自加拿大(8 人)、美国(3 人)、法国(1 人)、西班牙(1 人)、比利时(1 人)和黎巴嫩(1 人)。整个过程包括 4 轮德尔菲调查。评估类别包括:麻醉注意事项、术前和围手术期激光安全措施以及手术技术。最终调查完成后达成共识:通过改良的德尔菲法,国际合作开发了一种新型量表,用于评估住院医师在二氧化碳激光 MLS 方面的技能。未来的研究需要对这一评估工具进行验证。
{"title":"Development of the \"LAser Surgical skills Evaluation for Residents\" (LASER) Scale Through a Modified Delphi Method.","authors":"E Sédillot-Daniel, A Melkane, C Chiesa, N Fakhry, V N Young, L J Smith, J R Lechien, L Guertin, M J Olivier, A Maniakas, R Jun Lin, E Bissada, A Christopoulos, T Ayad, Andrée-Anne Leclerc","doi":"10.1177/19160216241278654","DOIUrl":"10.1177/19160216241278654","url":null,"abstract":"<p><strong>Background: </strong>The CO<sub>2</sub> laser is frequently used during microlaryngeal surgery (MLS) for a variety of pathology including laryngeal malignancy and stenosis. Learning how to use the laser safely is part of the curriculum for every otolaryngology resident. However, assessment of laryngoscopy technical skills can be challenging for supervisors, making it difficult to adequately provide feedback to trainees.</p><p><strong>Objectives: </strong>\"LAser Surgical skills Evaluation for Residents\" (LASER) Scale aims to facilitate the evaluation of residents' performance and promote constructive feedback.</p><p><strong>Methods: </strong>The initial evaluation grid was based on a literature review of CO<sub>2</sub> laser laryngoscopy (with an emphasis on indications, technique, safety, and efficacy) using Covidence systematic review software (Veritas Health Innovation). The final version was produced after 4 rounds of Delphi surveys.</p><p><strong>Results: </strong>This study was an international collaboration including 15 otolaryngologists with either laryngology or head and neck surgery subspecialties. Panelists were based in Canada (8), the United States (3), France (1), Spain (1), Belgium (1), and Lebanon (1). The process involved 4 rounds of Delphi surveys. Assessment categories included: anesthesia considerations, pre- and perioperative laser safety measures, and surgical technique. Consensus was reached on final survey completion.</p><p><strong>Conclusions: </strong>Through a modified Delphi method, a novel scale was developed through an international collaborative effort that evaluates resident skillset in CO<sub>2</sub> laser MLS. Future studies are warranted to validate this assessment tool.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241278654"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11526142/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142468074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Upfront Surgery Versus Upfront Concurrent Chemoradiotherapy as Primary Modality in Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. 下咽鳞状细胞癌前期手术与同期化放疗作为主要治疗方式的比较:系统回顾与 Meta 分析。
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241293633
Tsung-You Tsai, Wing-Keen Yap, Ting-Hao Wang, Yi-An Lu, Anna See, Yu-Feng Hu, Yenlin Huang, Huang-Kai Kao, Kai-Ping Chang

Importance: The management of hypopharyngeal squamous cell carcinoma (HPSCC) continues to be one of the most formidable challenges in the realm of head and neck oncology.

Objectives: The aim of this meta-analysis was to evaluate the disparity in survival outcomes between upfront surgery and upfront concurrent chemoradiotherapy as the primary treatment modality in patients with HPSCC.

Design: Systemic review with meta-analysis.

Setting: The meta-analysis was conducted in strict accordance with the PRISMA guideline. A literature search through PubMed, EMBASE, and the Cochrane Library were conducted until January 2023. The adjusted hazard ratio (aHR) with 95% confidence intervals (CIs) of different survival outcomes were extracted and pooled.

Participants: Studies that incorporated HPSCC patients without receiving induction chemotherapy.

Interventions: Upfront surgery versus upfront concurrent chemoradiotherapy.

Main outcome measures: Overall survival (OS) and disease-free survival (DFS).

Results: Eight studies published between 2015 and 2023, with a pooled patient population of 1619, were included in this meta-analysis. The outcomes reveal that upfront surgery was notably linked with improved OS (aHR 0.66, 95% CI 0.57-0.78) and DFS (aHR 0.75, 95% CI 0.63-0.90). Subgroup analyses were conducted to investigate the impact of the overall stage of the tumor and the extent of surgery on OS. In patients with advanced HPSCC (stages III and IV), upfront surgery remained associated with better OS (aHR 0.65, 95% CI 0.56-0.77). Concerning the extent of surgery, both subgroups exhibited a superior OS outcome associated with upfront surgery (exclusive total laryngopharyngectomy group: aHR 0.54, 95% CI 0.39-0.75; total/partial laryngopharyngectomy group: aHR 0.71, 95% CI 0.59-0.84).

Conclusions and relevance: The results demonstrated that upfront surgery showed better OS and DFS than concurrent chemoradiation and remind the clinicians of the potential reduction in survival outcomes when choosing concurrent chemoradiotherapy as primary treatment.

重要性:下咽鳞状细胞癌(HPSCC)的治疗仍然是头颈部肿瘤领域最严峻的挑战之一:本荟萃分析旨在评估下咽鳞状细胞癌(HPSCC)患者以前期手术和前期同步放化疗作为主要治疗方式的生存结果差异:设计:系统回顾与荟萃分析:荟萃分析严格按照PRISMA指南进行。截至 2023 年 1 月,在 PubMed、EMBASE 和 Cochrane 图书馆进行了文献检索。提取并汇总了不同生存结果的调整后危险比(aHR)及95%置信区间(CI):纳入未接受诱导化疗的HPSCC患者的研究:主要结局指标:总生存率(OS)和疾病生存率(CI):总生存期(OS)和无病生存期(DFS):本荟萃分析纳入了 2015 年至 2023 年间发表的 8 项研究,汇总患者人数为 1619 人。结果显示,前期手术与OS(aHR 0.66,95% CI 0.57-0.78)和DFS(aHR 0.75,95% CI 0.63-0.90)的改善有显著联系。为了研究肿瘤的总体分期和手术范围对OS的影响,我们进行了分组分析。在晚期HPSCC(III期和IV期)患者中,前期手术仍与较好的OS相关(aHR为0.65,95% CI为0.56-0.77)。在手术范围方面,两个亚组的患者均表现出与前期手术相关的较佳OS结果(完全全喉咽切除术组:aHR 0.54,95% CI 0.39-0.75;全/部分喉咽切除术组:aHR 0.71,95% CI 0.59-0.84):研究结果表明,与同期化放疗相比,前期手术显示出更好的OS和DFS,并提醒临床医生在选择同期化放疗作为主要治疗手段时,可能会降低生存率。
{"title":"Upfront Surgery Versus Upfront Concurrent Chemoradiotherapy as Primary Modality in Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.","authors":"Tsung-You Tsai, Wing-Keen Yap, Ting-Hao Wang, Yi-An Lu, Anna See, Yu-Feng Hu, Yenlin Huang, Huang-Kai Kao, Kai-Ping Chang","doi":"10.1177/19160216241293633","DOIUrl":"10.1177/19160216241293633","url":null,"abstract":"<p><strong>Importance: </strong>The management of hypopharyngeal squamous cell carcinoma (HPSCC) continues to be one of the most formidable challenges in the realm of head and neck oncology.</p><p><strong>Objectives: </strong>The aim of this meta-analysis was to evaluate the disparity in survival outcomes between upfront surgery and upfront concurrent chemoradiotherapy as the primary treatment modality in patients with HPSCC.</p><p><strong>Design: </strong>Systemic review with meta-analysis.</p><p><strong>Setting: </strong>The meta-analysis was conducted in strict accordance with the PRISMA guideline. A literature search through PubMed, EMBASE, and the Cochrane Library were conducted until January 2023. The adjusted hazard ratio (aHR) with 95% confidence intervals (CIs) of different survival outcomes were extracted and pooled.</p><p><strong>Participants: </strong>Studies that incorporated HPSCC patients without receiving induction chemotherapy.</p><p><strong>Interventions: </strong>Upfront surgery versus upfront concurrent chemoradiotherapy.</p><p><strong>Main outcome measures: </strong>Overall survival (OS) and disease-free survival (DFS).</p><p><strong>Results: </strong>Eight studies published between 2015 and 2023, with a pooled patient population of 1619, were included in this meta-analysis. The outcomes reveal that upfront surgery was notably linked with improved OS (aHR 0.66, 95% CI 0.57-0.78) and DFS (aHR 0.75, 95% CI 0.63-0.90). Subgroup analyses were conducted to investigate the impact of the overall stage of the tumor and the extent of surgery on OS. In patients with advanced HPSCC (stages III and IV), upfront surgery remained associated with better OS (aHR 0.65, 95% CI 0.56-0.77). Concerning the extent of surgery, both subgroups exhibited a superior OS outcome associated with upfront surgery (exclusive total laryngopharyngectomy group: aHR 0.54, 95% CI 0.39-0.75; total/partial laryngopharyngectomy group: aHR 0.71, 95% CI 0.59-0.84).</p><p><strong>Conclusions and relevance: </strong>The results demonstrated that upfront surgery showed better OS and DFS than concurrent chemoradiation and remind the clinicians of the potential reduction in survival outcomes when choosing concurrent chemoradiotherapy as primary treatment.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241293633"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11528607/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142522172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary Stapedectomy: A Retrospective Review of Surgical Results Using a Cold Steel Technique and Pre-Operative CT Correlates. 原发性镫骨切除术:使用冷钢技术和术前 CT 相关性对手术结果的回顾性研究。
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241288813
Thomas J Hudson, Tamara Mijovic, Jamie M Rappaport

Importance: Stapedectomy is an effective treatment option for patients with symptomatic otosclerosis. A common surgical technique today is laser stapedotomy, although the equipment required adds a significant cost to the procedure and may not be available in certain, particularly remote, centers. This study aimed to evaluate cold steel stapedectomy in a modern otology practice as a cost-effective and versatile alternative.

Objective: The primary objective was to evaluate the efficacy and safety of cold steel stapedectomy. The secondary objectives included characterizing the prevalence of relevant computed tomography (CT) findings and evaluating other factors such as piston size.

Design: A retrospective case series from April 2006 to November 2021.

Setting: A single tertiary care hospital in Montreal, QC, Canada.

Participants: Patients with suspected otosclerosis and no prior stapes surgery.

Intervention: Cold steel primary stapedectomy.

Main outcome measures: In primary analysis, change in pure tone thresholds, pure tone average (PTA), and complication rates were obtained. Secondary analysis measures included rates of relevant CT findings and change in PTA with piston size.

Results: A total of 302 cases were included in the analysis. The average change in air conduction PTA was a decrease of 27 dB, with 91% (276/302) having over 10 dB of improvement. The air-bone gap was closed to within 10 dB in 82% (248/302) of cases and within 20 dB in 96% (290/302) of cases. Overclosure occurred in 19% of cases, while only 4% resulted in worsened PTA bone conduction thresholds. In secondary analysis, 74% of CT scans demonstrated radiologic otosclerosis. Other findings included suspected superior semicircular canal dehiscence in 1.8%.

Conclusion: Cold steel stapedectomy was demonstrated to be a safe and effective technique, with audiometric results comparable to laser and drill studies in recent literature. It should be considered as a cost-effective and global health accessible alternative. Additionally, CT scans can provide valuable information in the pre-operative workup.

重要性:镫骨切除术是治疗无症状耳硬化症患者的有效方法。目前常见的手术技术是激光镫骨切除术,但所需设备会增加手术成本,而且某些中心,尤其是偏远地区的中心可能无法提供。本研究旨在评估冷钢镫骨切除术在现代耳科实践中的成本效益和通用性:主要目的是评估冷钢镫骨切除术的有效性和安全性。次要目标包括确定相关计算机断层扫描(CT)结果的发生率,并评估活塞大小等其他因素:设计:2006 年 4 月至 2021 年 11 月的回顾性病例系列:地点:加拿大 BC 省蒙特利尔市的一家三级医院:干预措施:冷钢镫骨初级切除术:主要结果测量:主要分析指标:纯音阈值变化、纯音平均值(PTA)和并发症发生率。次要分析指标包括相关 CT 结果的发生率和 PTA 随活塞大小的变化:共有 302 个病例纳入分析。气导 PTA 的平均变化降低了 27 分贝,91%(276/302)的病例改善了 10 分贝以上。82%的病例(248/302)的气-骨间隙闭合在 10 分贝以内,96%的病例(290/302)的气-骨间隙闭合在 20 分贝以内。19%的病例出现过度封闭,只有 4% 的病例导致 PTA 骨传导阈值恶化。在二次分析中,74% 的 CT 扫描显示出放射性耳硬化症。其他发现包括1.8%的病例疑似上半规管开裂:冷钢镫骨切除术被证明是一种安全有效的技术,其听力测定结果与近期文献中的激光和钻孔研究结果相当。冷钢镫骨切除术是一种安全有效的技术,其听力测定结果可与近期的激光和钻孔研究相媲美。此外,CT 扫描可为术前检查提供有价值的信息。
{"title":"Primary Stapedectomy: A Retrospective Review of Surgical Results Using a Cold Steel Technique and Pre-Operative CT Correlates.","authors":"Thomas J Hudson, Tamara Mijovic, Jamie M Rappaport","doi":"10.1177/19160216241288813","DOIUrl":"https://doi.org/10.1177/19160216241288813","url":null,"abstract":"<p><strong>Importance: </strong>Stapedectomy is an effective treatment option for patients with symptomatic otosclerosis. A common surgical technique today is laser stapedotomy, although the equipment required adds a significant cost to the procedure and may not be available in certain, particularly remote, centers. This study aimed to evaluate cold steel stapedectomy in a modern otology practice as a cost-effective and versatile alternative.</p><p><strong>Objective: </strong>The primary objective was to evaluate the efficacy and safety of cold steel stapedectomy. The secondary objectives included characterizing the prevalence of relevant computed tomography (CT) findings and evaluating other factors such as piston size.</p><p><strong>Design: </strong>A retrospective case series from April 2006 to November 2021.</p><p><strong>Setting: </strong>A single tertiary care hospital in Montreal, QC, Canada.</p><p><strong>Participants: </strong>Patients with suspected otosclerosis and no prior stapes surgery.</p><p><strong>Intervention: </strong>Cold steel primary stapedectomy.</p><p><strong>Main outcome measures: </strong>In primary analysis, change in pure tone thresholds, pure tone average (PTA), and complication rates were obtained. Secondary analysis measures included rates of relevant CT findings and change in PTA with piston size.</p><p><strong>Results: </strong>A total of 302 cases were included in the analysis. The average change in air conduction PTA was a decrease of 27 dB, with 91% (276/302) having over 10 dB of improvement. The air-bone gap was closed to within 10 dB in 82% (248/302) of cases and within 20 dB in 96% (290/302) of cases. Overclosure occurred in 19% of cases, while only 4% resulted in worsened PTA bone conduction thresholds. In secondary analysis, 74% of CT scans demonstrated radiologic otosclerosis. Other findings included suspected superior semicircular canal dehiscence in 1.8%.</p><p><strong>Conclusion: </strong>Cold steel stapedectomy was demonstrated to be a safe and effective technique, with audiometric results comparable to laser and drill studies in recent literature. It should be considered as a cost-effective and global health accessible alternative. Additionally, CT scans can provide valuable information in the pre-operative workup.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241288813"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11475111/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142468087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Factors of Hearing Improvement for EES and MES in Attic Cholesteatoma. 房角胆脂瘤患者听力改善的 EES 和 MES 预后因素
IF 2.6 3区 医学 Q1 OTORHINOLARYNGOLOGY Pub Date : 2024-01-01 DOI: 10.1177/19160216241286794
Minqian Gao, Nan Zeng, Weibiao Kang, Yong Lin, Peng Li, Yuan Tao, Yongtian Lu, Wei Zhao, Xiangwei Chen, Zebin Jiang, Jinliang Gao, Youjun Yu, Wanshan Liang, Sijia Zhai, Qiong Yang, Haidi Yang

Objective: The surgical strategy of cholesteatomas is still controversial. This study aimed to compare the hearing improvement and determine the prognostic factors between endoscopic and microscopic ear surgery for attic cholesteatoma via a multicenter retrospective study.

Methods: This retrospective study included 169 patients with attic cholesteatoma who received endoscopic ear surgery (EES) or microscopic ear surgery (MES) from 12 otorhinolaryngology centers. Hearing improvement between EES and MES was evaluated, including the postoperative pure tone average (PTA) and air-bone gap (A-B Gap), as well as the hearing threshold across the low-, mid-, and high-frequency. The success rate of grafts was collected. Linear regression was performed to access the prognostic value of preoperative PTA and A-B Gap. Patients were followed up for at least 3 years.

Results: The graft success rate of EES was 89.66% (78/87) versus 80.49% (66/82) for MES. The postoperative PTA and A-B Gap demonstrated significant improvement in EES compared to MES (Post-PTA: t = 3.281, P = .001; Post-A-B Gap: t = 2.197, P = .029). In the EES group, there were 59 ears (67.82%) with a postoperative A-B Gap ≤20 dB HL, which revealed a higher rate of successful hearing outcomes in EES as opposed to MES (χ2 = 9.904, P = .019). There were significantly better hearing improvement, shorter surgical times, and lower hospital stays in EES for epitympanic cholesteatoma without stapes superstructure involvement. The preoperative AC ≤79 dB and/or preoperative A-B Gap ≤52 dB was associated with a better prognosis in EES for epitympanic cholesteatoma with stapes superstructure involvement.

Conclusions: EES showed higher graft success rate, better hearing improvement, shorter surgical times and hospital stays for attic cholesteatoma, particularly without stapes superstructure involvement. The range of preoperative PTA and A-B Gap have shown the prognostic value, which maybe a favorable surgical indication for EES or MES.

目的:胆脂瘤的手术策略仍存在争议。本研究旨在通过一项多中心回顾性研究,比较内窥镜和显微耳手术治疗阁楼胆脂瘤的听力改善情况,并确定预后因素:这项回顾性研究纳入了来自12个耳鼻喉科中心的169名阁楼胆脂瘤患者,他们分别接受了内窥镜耳部手术(EES)或显微镜耳部手术(MES)。对 EES 和 MES 的听力改善情况进行了评估,包括术后纯音平均值(PTA)和气-骨间隙(A-B 间隙),以及低、中、高频听阈。还收集了移植物的成功率。对术前 PTA 和 A-B 间隙的预后价值进行了线性回归分析。对患者进行了至少 3 年的随访:结果:EES 的移植成功率为 89.66%(78/87),而 MES 为 80.49%(66/82)。术后PTA和A-B间隙与MES相比有显著改善(术后PTA:t = 3.281,P = .001;术后A-B间隙:t = 2.197,P = .029)。在 EES 组中,有 59 耳(67.82%)的术后 A-B 间隙小于 20 dB HL,这表明 EES 的听力成功率高于 MES(χ2 = 9.904,P = .019)。对于没有镫骨上部结构受累的上鼓室胆脂瘤,EES的听力改善明显更好,手术时间更短,住院时间更短。术前AC≤79 dB和/或术前A-B间隙≤52 dB与EES治疗镫骨上部结构受累的上鼓室胆脂瘤的预后较好有关:EES治疗阁楼胆脂瘤,尤其是未累及镫骨上部结构的患者,移植成功率更高,听力改善更好,手术时间和住院时间更短。术前 PTA 和 A-B Gap 的范围显示了预后价值,这可能是 EES 或 MES 的有利手术指征。
{"title":"Prognostic Factors of Hearing Improvement for EES and MES in Attic Cholesteatoma.","authors":"Minqian Gao, Nan Zeng, Weibiao Kang, Yong Lin, Peng Li, Yuan Tao, Yongtian Lu, Wei Zhao, Xiangwei Chen, Zebin Jiang, Jinliang Gao, Youjun Yu, Wanshan Liang, Sijia Zhai, Qiong Yang, Haidi Yang","doi":"10.1177/19160216241286794","DOIUrl":"10.1177/19160216241286794","url":null,"abstract":"<p><strong>Objective: </strong>The surgical strategy of cholesteatomas is still controversial. This study aimed to compare the hearing improvement and determine the prognostic factors between endoscopic and microscopic ear surgery for attic cholesteatoma via a multicenter retrospective study.</p><p><strong>Methods: </strong>This retrospective study included 169 patients with attic cholesteatoma who received endoscopic ear surgery (EES) or microscopic ear surgery (MES) from 12 otorhinolaryngology centers. Hearing improvement between EES and MES was evaluated, including the postoperative pure tone average (PTA) and air-bone gap (A-B Gap), as well as the hearing threshold across the low-, mid-, and high-frequency. The success rate of grafts was collected. Linear regression was performed to access the prognostic value of preoperative PTA and A-B Gap. Patients were followed up for at least 3 years.</p><p><strong>Results: </strong>The graft success rate of EES was 89.66% (78/87) versus 80.49% (66/82) for MES. The postoperative PTA and A-B Gap demonstrated significant improvement in EES compared to MES (Post-PTA: <i>t</i> = 3.281, <i>P</i> = .001; Post-A-B Gap: <i>t</i> = 2.197, <i>P</i> = .029). In the EES group, there were 59 ears (67.82%) with a postoperative A-B Gap ≤20 dB HL, which revealed a higher rate of successful hearing outcomes in EES as opposed to MES (χ<sup>2</sup> = 9.904, <i>P</i> = .019). There were significantly better hearing improvement, shorter surgical times, and lower hospital stays in EES for epitympanic cholesteatoma without stapes superstructure involvement. The preoperative AC ≤79 dB and/or preoperative A-B Gap ≤52 dB was associated with a better prognosis in EES for epitympanic cholesteatoma with stapes superstructure involvement.</p><p><strong>Conclusions: </strong>EES showed higher graft success rate, better hearing improvement, shorter surgical times and hospital stays for attic cholesteatoma, particularly without stapes superstructure involvement. The range of preoperative PTA and A-B Gap have shown the prognostic value, which maybe a favorable surgical indication for EES or MES.</p>","PeriodicalId":16615,"journal":{"name":"Journal of Otolaryngology - Head & Neck Surgery","volume":"53 ","pages":"19160216241286794"},"PeriodicalIF":2.6,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11487515/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142468088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Otolaryngology - Head & Neck Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1